OxySure Therapeutics (OXYS) Inactive 10-K31 Mar 152014 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2014	Mar. 27, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	OxySure Systems Inc
Entity Central Index Key	1413797
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-K
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$4,383,261
Entity Common Stock, Shares Outstanding		29,573,414

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$647,093	$657,673
Accounts receivable, net	369,575	47,183
Inventories	277,346	287,666
License fee receivable	463,308	500,000
Prepaid expenses and other current assets	53,588	107,305
Total current assets	1,810,910	1,599,827
Property and equipment, net	91,537	70,249
Intangible assets, net	362,764	392,746
Other assets, net	246,237	289,532
TOTAL ASSETS	2,511,448	2,352,354
Current liabilities
Accounts payable and accrued expenses	558,338	147,719
Related party payable	154,850	118,627
Deferred revenue		2,976
Capital leases - current	149	309,129
Notes payable - current, net of discount	40,897	44,000
Convertible notes payable, net of discount	606,932	229,903
Derivative liability	31,010
Total current liabilities	1,392,176	852,354
Long-term liabilities
Capital leases		554
Notes payable, net of discount	44,484	76,072
Total long-term liabilities	44,484	76,626
TOTAL LIABILITIES	1,436,660	928,980
COMMITMENTS AND CONTINGENCY (NOTE 9)
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, par value $0.0004 per share; 100,000,000 shares authorized; 28,438,631 shares of voting common stock issued and outstanding as of December 31, 2014 and 25,854,307 shares issued and outstanding as of December 31, 2013	11,377	10,343
Additional Paid-in Capital	19,104,322	16,700,307
Accumulated deficit	-18,041,208	-15,287,647
TOTAL STOCKHOLDERS' EQUITY	1,074,788	1,423,374
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	2,511,448	2,352,354
Series A Preferred Stock [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, par value $0.0005 per share; 25,000,000 shares authorized;	296	371
Series B Preferred Stock [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, par value $0.0005 per share; 25,000,000 shares authorized;

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Voting common stock, shares issued	28,438,631	25,854,307
Voting common stock, shares outstanding	28,438,430	25,854,307
Series A Preferred Stock [Member]
Preferred Stock, shares issued	593,750	743,750
Preferred stock, shares outstanding	593,750	743,750
Series B Preferred Stock [Member]
Preferred Stock, shares issued	1,145	750
Preferred stock, shares outstanding	1,145	750

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended
Statements of Operations (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Revenues, net	$2,437,402	$1,800,327
Cost of goods sold	1,419,047	592,986
Gross profit	1,018,355	1,207,341
Operating expenses
Research and development	583,435	356,015
Sales and marketing	718,705	353,156
Other general and administrative	1,751,006	986,468
Loss from operations	-2,034,791	-488,298
Other income (expenses)
Other income (expense)	188,843	25,825
Interest expense	-907,612	-249,979
Total other income (expenses)	-718,769	-224,154
Net loss	($2,753,560)	($712,452)
Basic net income (loss) per common share	($0.10)	($0.03)
Diluted net income (loss) per common share	($0.10)	($0.03)
Weighted average common shares outstanding:
Basic	26,367,254	23,754,402
Diluted	26,367,254	23,754,402

Statement_of_Stockholders_Equi

Statement of Stockholders' Equity (USD $)	Total	Convertible Preferred Stock Series A [Member]	Convertible Preferred Stock Series B [Member]	Common stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2012	($916,335)	$409		$9,020	$13,649,431	($14,575,195)
Beginning Balance, Shares at Dec. 31, 2012		818,750		22,548,678
Common stock issued upon conversion of convertible preferred stock		-38		37	1
Common stock issued upon conversion of convertible preferred stock, Shares		-75,000		91,500
Series B preferred stock and warrants issued for cash	-750,000				750,000
Series B preferred stock and warrants issued for cash, Shares			750
Common stock issued for cash and warrants	-216,800			174	216,626
Common stock issued for cash and warrants, Shares				435,000
Common stock issued for cash	347,364			268	347,096
Common stock issued for cash, Shares				670,947
Common stock issued upon conversion of convertible notes	462,448			193	462,255
Common stock issued upon conversion of convertible notes, Shares				482,934
Common stock issued for exercising options and warrants	4,388			176	4,212
Common stock issued for exercising options and warrants, Shares				438,888
Common stock issued for services	257,837			129	257,708
Common stock issued for services, Shares				322,000
Common stock issued for conversion of rent	423,413			258	423,155
Common stock issued for conversion of rent, Shares				644,347
Stock Issued During Period Shares Prepaid Rent				220,013
Stock Issued During Period Value Prepaid Rent	162,810			88	162,722
Stock based compensation expense	61,480				61,480
Beneficial conversion feature	317,609				317,609
Deferred loan costs	48,012				48,012
Net loss	-712,452					-712,452
Ending Balance at Dec. 31, 2013	1,423,374	371		10,343	16,700,307	-15,287,647
Ending Balance, Shares at Dec. 31, 2013		743,750	750	25,854,307
Common stock issued upon conversion of convertible preferred stock		-75		73	2
Common stock issued upon conversion of convertible preferred stock, Shares		-150,000		183,000
Series B preferred stock and warrants issued for cash	0		0	95	-95
Series B preferred stock and warrants issued for cash, Shares			-130	236,364
Common stock issued for cash and warrants	525,000		0		525,000
Common stock issued for cash and warrants, Shares			525
Common stock issued for cash	29,700			17	29,683
Common stock issued for cash, Shares				41,580
Common stock issued upon conversion of convertible notes	625,913			612	625,301
Common stock issued upon conversion of convertible notes, Shares				1,529,734
Common stock issued for exercising options and warrants	4,370			175	4,195
Common stock issued for exercising options and warrants, Shares				436,945
Common stock issued for services	64,874			32	64,842
Common stock issued for services, Shares	81,500			81,500
Common stock issued for conversion of rent
Common stock issued for conversion of rent, Shares
Common stock issued in connection with lease extinguishment	66,750			30	66,720
Common stock issued in connection of lease extinguishment, Shares				75,000
Stock based compensation expense	136,944				136,944
Beneficial conversion feature	951,423				951,423
Deferred loan costs
Net loss	-2,753,560					-2,753,560
Ending Balance at Dec. 31, 2014	$1,074,788	$296		$11,377	$19,104,322	($18,041,208)
Ending Balance, Shares at Dec. 31, 2014		593,750	1,145	28,438,430

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
Statements of Cash Flows (USD $)	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	($2,753,560)	($712,452)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization expense	42,151	53,159
Amortization of debt discount and beneficial conversion features	747,612	207,239
Gain on forgiveness of debt	14,466
Gain on settlement of debt	-90,912
Derivative liability fair value adjustment	3,001
Expenses paid by related parties	4,374	37,335
Expenses paid by third party	150,000
Stock based compensation	136,944	61,480
Common stock issued for services	64,873	126,756
Changes in operating assets and liabilities:
Accounts receivable	-322,392	-28,697
Inventories	10,320	-66,321
License fees receivable	36,692	-500,000
Other assets	125,531	106,148
Accounts payable and accrued liabilities	763,046	-72,601
Prepaid expense	-28,519
Deferred revenue	-2,976	-72,837
NET CASH USED IN OPERATING ACTIVITIES	-1,099,349	-860,791
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	-68,080	-12,105
Purchase of intangible assets	-198	-4,262
NET CASH USED IN INVESTING ACTIVITIES	-68,278	-16,367
CASH FLOWS FROM FINANCING ACTIVITIES
Common stock issued for cash	29,701	347,364
Series B preferred stock issued for cash and warrants	0	750,000
Common stock issued for cash and warrants	-525,000	216,800
Cash received from related parties	9,800	42,470
Payments made to related parties	-227,951	-268,950
Payments made on notes payable
Cash received from convertible notes payable	1,168,200	431,500
Payments made on convertible notes payable	-200,201
Payments on capital leases	-151,872	-2,254
Exercising of warrants	4,370	4,388
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,157,047	1,521,318
Net change in cash and cash equivalents	-10,580	644,160
Cash and cash equivalents, at beginning of period	657,673	13,513
Cash and cash equivalents, at end of period	647,093	657,673
Cash paid during the period for:
Interest		18,792
Income taxes
Supplemental non-cash investing and financing activities:
Initial value of derivative	28,009
Capitalization of deferred loan costs		48,012
Common stock issued for services and rent extension		179,710
Common stock issued for capitalized website development costs		114,180
Common stock issued in connection with lease extinguishment	66,750
Cashless exercise of warrants for forgiveness of debt		14,700
Conversion of convertible notes payable	625,913	447,748
Beneficial conversion feature	951,423	317,609
Conversion of Series A preferred stock to common stock	74	38
Conversion of accrued rent to common stock		$423,413

Organization_and_Summary_of_Si

Organization and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Organization and Summary of Significant Accounting Policies [Abstract]
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



	A summary of significant accounting policies of OxySure Systems, Inc. (“we,” “us,” “our,” “OxySure” or the “Company”) is presented to assist in understanding the Company’s financial statements. The accounting policies presented in these footnotes conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. These financial statements and notes are representations of the Company’s management who are responsible for their integrity and objectivity.



	Organization: OxySure Systems, Inc. (OTCQB: OXYS) was incorporated on January 15, 2004 as a Delaware corporation. Our headquarters is located in Frisco, Texas and we are a medical device innovator focused on the design, manufacture and distribution of specialty respiratory and emergency medical solutions. We pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. We own nine (9) issued patents and several additional patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. Our products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.



	We launched our first product utilizing this technology – a portable emergency oxygen system for lay person use, called the OxySure Model 615. On December 9, 2005, we received approval from the Food and Drug Administration (510K, Class II) for Model 615. The approval number for our FDA clearance is K052396, and Model 615 is cleared for over the counter sale, without the need for a prescription. In February 2014 we received CE Marking approval for the OxySure portable emergency oxygen generator.



	The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.



	While the Company has effectively managed its working capital deficit the going concern risk remains an issue for the company to manage. The Company has implemented, and plans to further implement several different strategies in order to help the Company ease the going concern issue. Refer to Note 13, “Going concern” of the Notes to Financial Statements for a partial list of the Company’s plans to mitigate the going concern issue.



	Basis of Presentation - Management acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company’s system of internal accounting control is designed to assure, among other items, that (1) recorded transactions are valid; (2) all valid transactions are recorded; and (3) transactions are recorded in the period in a timely manner to produce financial statements which present fairly the financial condition of the Company.



	Use of estimates - The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimated.



	Revenue Recognition - We recognize revenue when persuasive evidence of an arrangement exists, shipment has occurred, the price is fixed or determinable, and collectability is reasonably assured. Revenues are recognized from product sales, net of discounts and rebates. This revenue recognition policy is applied to both customers and distributors.



	Fees from licensees desiring to manufacture and distribute our products or derivative products using our intellectual property include initial license fees and royalties. Initial license fees are generally recognized upon granting of the license to the licensee. Royalties are recognized in the period earned.



	Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was and $0 and $2,976 for the years ended December 31, 2014 and 2013 respectively.



	Cash and Cash Equivalents - Cash consists of all highly liquid investments purchased with maturity of three months or less to be cash equivalents. Cash and cash equivalents may at times exceed Federally-insured limits. To minimize this risk, we place our cash and cash equivalents with high credit quality institutions.



	Inventories – Our inventories consist of raw material and components for our portable oxygen systems as well as completed products and accessories. Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer. We write down our inventory value for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. These factors are impacted by market and economic conditions, technology changes, new product introductions and changes in strategic direction and require estimates that may include uncertain elements. Actual demand may differ from forecasted demand, and such differences may have a material effect on recorded inventory values. Management has established inventory reserves to cover estimated inventory losses for all work-in-process and finished goods related to products we manufactured, as well as raw material and components for those products that had no potential use in products to be manufactured in the future. Management is required to make judgments about the future benefit of our raw materials and components. Actual reserve requirements could differ significantly from Management’s estimates, which could have a significant unfavorable impact on our future gross margins.



	At December 31, 2014 and December 31, 2013 inventories consisted of the following:



			December 31,
			2014			2013
	Raw materials		$	133,477		$	145,827
	Work in process			41,114			78,809
	Finished goods			102,755			63,030

			$	277,346		$	287,666



Concentration of Credit Risk – We sell our products throughout the United States as well as in certain other countries. Sales to its recurring customers in the United States are generally granted on net 30-day credit terms. We perform periodic credit evaluations of our recurring customers and generally do not require collateral. In general, we require prepayment on all sales to customers outside the United States. An allowance for doubtful accounts is maintained for potential credit losses, which losses historically have not been significant.



We invest our cash in deposits and money market funds with major financial institutions. We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.



Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable. We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:



Level 1: Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

Level 2: Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.



The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.



Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years. Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms. Depreciation expense was $11,970 and $23,165 for the years ended December 31, 2014 and 2013, respectively.



Property and equipment consist of the following:



		December 31,
		2014			2013

Leasehold Improvements			547,856			547,856
Machinery and equipment on capital leases			919,736			919,736
Property, plant and equipment			237,484			196,051
Furniture and fixtures			34,821			16,254
Computers and software			55,368			47,288

			1,795,265			1,727,185

Less: accumulated depreciation			(1,703,727	)		(1,656,936	)

			91,537			70,249



Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization.



Amortization expense for patents and trademarks was $30,180 and $29,995 for the years ended December 31, 2014 and 2013, respectively.



Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified. Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. Certain events and circumstances we considered in determining whether the carrying value of identifiable intangible assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in its business strategy. In determining if impairment exists, we estimate the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the years ended December 31, 2014 and 2013.



Other Assets – We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $92,612 and $102,404 for the years ended December 31, 2014 and 2013, respectively.



Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.



Allowance for Doubtful Accounts - We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make payments. We periodically review these allowances, including an analysis of the customers’ payment history and information regarding the customers’ creditworthiness. Actual write-offs have not been materially different from the estimated allowance. We recorded bad debt expense of $2,443 and $23,194 for the years ended December 31, 2014 and 2013, respectively.



Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred. $583,435 and $356,015 were incurred in the years ended December 31, 2014 and 2013, respectively.



Income Taxes – In accordance with Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes” (“ASC 740”), we account for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our Consolidated Financial Statements, but have not been reflected in our taxable income. A valuation allowance has been established to reduce deferred tax assets to their estimated realizable value. Therefore, we provide a valuation allowance to the extent that we do not believe it is more likely than not that we will generate sufficient taxable income in future periods to realize the benefit of our deferred tax assets. We recognize interest and penalties related to unrecognized tax benefits in income tax expense.



Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties. We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model, which was developed for use in estimating the value of traded options that have no vesting restrictions and that are freely transferable. The Black-Scholes model requires the input of certain assumptions. Changes in the assumptions used in Black-Scholes model can materially affect the fair value estimates. We evaluate the assumptions used to value stock options on an annual basis. The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.



The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by employees. Upon the adoption of the accounting guidance, we continued to use historical volatility in deriving the expected volatility assumption as allowed under GAAP because we believe that future volatility over the expected term of the stock options is not likely to differ materially from the past. The risk-free interest rate assumption is based on 5-year U.S Treasury zero-coupon rates appropriate for the expected term of the stock options. The expected dividend assumption is based on the history and expectation of dividend payouts. The fair values generated by the Black-Scholes model may not be indicative of the actual fair values of the equity awards, as we do not consider other factors important to those awards to employees, such as continued employment, periodic vesting requirements and limited transferability. The amount of stock based compensation expenses is net of an estimated forfeiture rate, which is also based on historical data. For the years ended December 31, 2014 and 2013, stock based compensation expense was approximately $136,944 and $61,480 respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to the employees.



The Company follows ASC Topic 505-50, formerly EITF 96-18, “Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling Goods and Services,” for stock options and warrants issued to consultants and other non-employees. In accordance with ASC Topic 505-50, these stock options and warrants issued as compensation for services to be provided to the Company are accounted for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can be more clearly determined. We recognize this expense over the period in which the services are provided. For the years ended December 31, 2014 and 2013, stock based compensation expense was approximately $0 in each year, which consisted primarily of stock-based compensation expense related to stock options and warrants recognized under GAAP issued to consultants and other non-employees.



The following table shows the components of our stock based compensation expense for employees, consultants and other non-employees:



		Year ended
		December 31,
		2014			2013

Common Stock options issued for compensation		$	108,244		$	61,480
Common Stock options and warrants issued for services			28,700			-

Total		$	136,944		$	61,480



Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.



Advertising Costs - Advertising costs are charged to operations when incurred. During the years ended December 31, 2014 and 2013 we incurred $718,705 and $353,156 respectively, in advertising and promotion costs.



Litigation and Settlement Costs - Legal costs are expensed as incurred. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) accrue the best estimate within a range of loss if there is a loss or, when there is no amount within a range that forms a better estimate, we will accrue the minimum amount in the range.



Loss Per Share - Basic loss per share, which excludes anti-dilutive securities, is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding for that particular period. In contrast, diluted loss per share considers the potential dilution that could occur from other equity instruments that would increase the total number of outstanding shares of common stock. Such amounts include shares potentially issuable under outstanding options, warrants, convertible preferred stock and convertible notes.



A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share follows:



		Year ended
		December 31,
		2014			2013
Historical net loss per share:

Numerator
Net loss, as reported			(2,753,560	)		(712,452	)
Less: Effect of amortization of interest expense on convertible notes			-			-
Net loss attributed to common stockholders (diluted)			(2,753,560	)		(712,452	)

Denominator
Weighted-average common shares outstanding			26,406,409			23,754,402
Effect of dilutive securities			-			-
Denominator for diluted net loss per share			26,406,409			23,754,402
Basic and diluted net loss per share		$	(0.10	)	$	(0.03	)



Basic and Diluted Loss per Share:



The computation of basic earnings per share of common stock is based on the weighted average number of shares outstanding during the periods presented. The computation of fully diluted earnings per share includes common stock equivalents outstanding at the balance sheet date. The Company had 3,757,583 and 1,635,694 stock options, warrants and convertible note shares that would have been included in the fully diluted earnings per share as of December 31, 2014 and 2013, respectively. However, the common stock equivalents were not included in the computation of the loss per share computation because they are anti-dilutive.



Reclassifications - Certain financial statement items have been reclassified to conform to the current year’s presentation.



Recent Accounting Pronouncements



We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

Intangible_Assets

Intangible Assets	12 Months Ended
Intangible Assets	Dec. 31, 2014
Intangible Assets [Abstract]
INTANGIBLE ASSETS	NOTE 2 – INTANGIBLE ASSETS



	We have two types of intangible assets: patents and trademarks. We capitalize expenditures associated with patents and trademarks related to our various technologies. Capitalized costs include amounts paid to third parties for legal fees, application fees and other direct costs incurred in the filing and prosecution of patent and trademark applications. These assets are amortized on a straight-line method over their legal life.



	Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable in accordance with applicable accounting guidance. During the years ended December 31, 2014 and 2013 we have had no impairment of intangible assets.



	The carrying values of our amortized acquired intangible assets as of the December 31, 2014 and 2013, respectively, are as follows:



		31-Dec-14							31-Dec-13
		Gross		Accumulated Amortization and write off			Net		Gross		Accumulated Amortization and write off			Net

	Patents	$	618,150	$	(287,662	)	$	330,488	$	617,651	$	(260,171	)	$	357,480
	Trademarks	$	45,723	$	(13,447	)	$	32,276	$	45,723	$	(10,758	)	$	34,965
		$	663,873	$	(301,109	)	$	362,764	$	663,374	$	(270,929	)	$	392,445



	As of December 31, 2014, we estimate the future amortization expense of the intangible assets for December 31, 2015, 2016 2017 and 2018, to be as follows:



	2015	$	30,232
	2016		30,232
	2017		30,232
	2018		30,232
	Thereafter		241,837
		$	362,764



	Due to the nature of the intangible assets, we have amortized the cost of the patents and trademarks over their estimated useful lives. The nature of the estimate did not change from 2013 to 2014. Of the net amount of $362,764 in intangible assets as of December 31, 2014, approximately 91% is in patents and 9% is in trademarks. Included in the $663,873 gross amount for patents and trademarks is $156,002 acquired from entities controlled by the founder of the Company in January 2004. The remaining $507,871 represents amounts paid to third parties for legal fees, application fees and other direct costs incurred in the filing and prosecution of patent and trademark applications.

Notes_Payable

Notes Payable	12 Months Ended
Notes Payable	Dec. 31, 2014
Notes Payable [Abstract]
NOTES PAYABLE	NOTE 3 – NOTES PAYABLE



	Frisco Promissory Note. On March 22, 2011 we entered into an Amended and Restated Performance Agreement with the Frisco Economic Development Corporation (“FEDC”) pursuant to an economic incentive package. In terms of the Amended and Restated Performance Agreement, the FEDC provided us with economic assistance in the form of the renewal and extension a forgivable loan of $213,000 (the “Frisco Note”) together with performance credits over 5 years, commencing on March 22, 2011 and ending on the earlier to occur of: (i) the full payment of the economic incentives; or (ii) March 31, 2016.



	The Frisco Note requires varying annual principal payments through December 2015. The Frisco Note is non-interest bearing; however, interest has been imputed at 12.34% per annum. The unamortized discount at December 31, 2014 was $15,516, and the net amount of the Frisco Note as at December 31, 2014 was $88,484.



	Future principal payments of the Frisco Note payable are as follows:



	2015			52,000
	2016			52,000
			$	104,000



	The following table reflects the carrying values of our short-term and long-term notes payable as of December 31, 2014.



			Effective Interest Rate				Principal			Accrued Interest			Discount			December 31,
			Effective Interest Rate				Principal			Accrued Interest			Discount			2014

	Current notes payable
	Iliad Trading and Research Notes			1.5	%			157,458			2,346			-			159,804
	Union Capital Funding Notes			69.9	%			297,000			4,680			202,843			98,837
	JSJ Investments Notes			37.3	%			300,000			10,685			101,124			209,561
	Sojourn Note			92.9	%			30,000			819			27,041			3,778
	WHC Capital Note			74.5	%			38,500			405			28,293			10,612
	Group 10 Notes			64.3	%			236,000			2,716			148,963			89,753
	GEL Notes			66.8	%			165,000			1,465			108,761			57,704
	Frisco EDC			12.3	%			104,000			-			15,516			88,484

	Total short-term notes payable						$	1,327,958		$	23,116		$	632,542		$	718,533

	Long-term notes payable
	none						$	-			-			-		$	0

	Total long-term notes payable						$	0		$	0		$	0		$	0
	Total short-term and long-term notes payable						$	1,327,958		$	23,116		$	632,541		$	718,533



	The following table reflects the carrying values of our short-term and long-term notes payable as of December 31, 2013.



			Effective Interest Rate				Principal			Accrued Interest			Discount			December 31,
			Effective Interest Rate				Principal			Accrued Interest			Discount			2013

	Current notes payable
	Iliad Trading and Research Notes			47.3	%			165,000			5,004			72,980			97,024
	LG Capital Funding			53.7	%			57,500			3,008			27,886			32,622
	JMJ Financial			70.4	%			110,000			13,200			64,195			59,005
	Tonaquint, Inc.			47	%			105,000			6,785			42,535			69,250
	Frisco EDC			12.34	%			44,000			-			-			44,000

	Total short-term notes payable						$	481,500		$	27,997		$	207,596		$	301,901

Long-term notes payable
Frisco EDC			12.34	%		$	104,000			-			27,928		$	76,072

Total long-term notes payable						$	104,000		$	0		$	27,928		$	76,072
Total short-term and long-term notes payable						$	585,500		$	27,997		$	235,524		$	377,973

Aggregate maturities of debt are as follows:



		As of
		December 31,
		2014

2015		$	718,533
Thereafter			-
Total		$	718,533

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2014
Shareholders' Equity [Abstract]
SHAREHOLDERS' EQUITY	NOTE 4 - SHAREHOLDERS’ EQUITY



	Preferred Shares Rights



	We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share.



	Series A Convertible Preferred Stock: As of December 31, 2014, the Company had authorized the issuance of 3,143,237 shares of preferred stock designated as Series A Convertible Preferred Stock (“Series A Preferred”). The original issue price of the Series A Preferred is $1.00 per share. There were 593,750 and 743,750 Series A Preferred shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively.



	During the year ended December 31, 2014 approximately 150,000 shares of the Series A Preferred have been converted into approximately 183,000 shares of our common stock in cashless conversions at a conversion ratio of 1.22:1.



	A summary of the designations and preferences of its Series A Preferred stock is as follows:



	Ranking – The Series A Preferred ranks senior to common stock.



	Dividends – Series A Preferred may be entitled to receive a quarterly non-cumulative dividend in the amount of $.01 per share upon approval from the Board of Directors.



	Liquidation Preference – In the event of any liquidation, dissolution, or winding up of the Company, the holders of Series A Preferred are entitled to receive 100% of the original issue price of $1.00 per share.



	Conversion Rights – Each share of Series A Preferred is convertible at any time, at the option of the holder into 1.22 shares of common stock, subject to adjustment. Series A Preferred are subject to automatic conversion upon consummation of underwritten offering by the Company of shares of common stock to the public, in which the aggregate cash proceeds are at least $3 million and the price paid per share is at least $5.00.



	Redemption Rights – All of the Series A Preferred may be called at any time by the Company within ten years, but not prior to two years after issuance. The redemption value is $1.00 per share, plus an amount equal to all unpaid dividends thereon.



	Voting Rights – The holder of each share of Series A Preferred has the right to one vote for each share of common stock into which such share of Series A Preferred could be converted.



	Series B Convertible Preferred Stock: On December 19, 2013, the Company’s Board of Directors authorized the issuance of 750 shares of preferred stock designated as Series B Convertible Preferred Stock (“Series B Preferred”). On December 23, 2014 we further increased the authorized shares of the Series B Preferred to 3,500 shares. The original issue price of the Series B Preferred is $1,000 per share. There were 1,145 and 750 Series B Preferred shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively.



	During the year ended December 31, 2014 we issued 525 shares of the Series B Preferred and 130 shares of Series B Preferred were converted into 236,364 shares of common stock.



	A summary of the designations and preferences of its Series B Preferred stock is as follows:



	Ranking – The Series B Preferred ranks senior to Series A Preferred and common stock.



Dividends – Series B Preferred accrues an annual dividend of 6 percent payable at the option of the Company, in cash, or in duly authorized, validly issued, fully paid and non-assessable shares of common stock.



Liquidation Preference – In the event of any liquidation, dissolution, or winding up of the Company, the holders of Series B Preferred are entitled to receive 100% of the original issue price of $1,000 per share, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing.



Conversion Rights – The conversion price for the Series B Preferred is equal to $0.55 per share of common stock.



Redemption Rights – The Company has no right to require holders of Series B Preferred to surrender their Series B Preferred for redemption.



Voting Rights – The holder of each share of Series B Preferred has the right to one vote for each share of common stock into which such share of Series B Preferred could be converted.



Common Stock



The Company has authorized 100,000,000 shares of $0.0004 par value common stock.



During the year ended December 31, 2014:



	-1	We issued 183,000 shares of common stock pursuant to the cashless conversion of 150,000 shares of Series A Preferred.
	-2	We issued 236,364 shares of common stock pursuant to the cashless conversion of 130 shares of Series B Preferred.
	-3	We issued 41,580 shares of common stock for $29,700 in cash.
	-4	We issued 1,529,734 shares of common stock upon the cashless conversion of convertible notes valued at $625,913.
	-5	We issued 436,945 shares of common stock upon conversion of options and warrants valued at $4,370.
	-6	We issued 81,500 shares of common stock for services valued at $64,875.
	-7	We issued 75,000 shares of common stock valued at $66,750 in connection with a lease extinguishment.
	-8	As further discussed under Note 6 – Stock Options and Warrants, we recorded $136,944 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures.
	-9	We recorded $951,423 in connection with beneficial conversion features.



During the year ended December 31, 2013:



	-1	We issued approximately 482,934 shares of common stock pursuant to the conversion of convertible notes valued at $462,448 in cash at an aggregate price of $.96 per share.
	-2	We issued approximately 670,947 shares of common stock for $347,364 in cash at an aggregate price of $.52 per share.
	-3	We issued approximately 435,000 shares of common stock and warrants for $216,800 in cash at an aggregate price of $.50 per unit.
	-4	We received proceeds of approximately $4,388 from the issuance of 438,888 shares of common stock pursuant to the exercise of 438,888 warrants.
	-5	We issued approximately 322,000 shares of common stock for services valued at $257,837 at an aggregate price of $.80 per share.
	-6	We issued 644,347 shares of common stock for conversion of rent valued at approximately $423,413.
	-7	We issued approximately 220,013 shares of common stock in connection with deferred rent valued at approximately $162,810 at an aggregate price of $.66 per share.
	-8	We issued approximately 132,000 shares valued at $114,180 in connection with capitalized website development costs and URLs.
	-9	We issued 91,500 shares of common stock pursuant to the cashless conversion of 75,000 shares of our Series A Preferred at a conversion ratio of 1.22:1.
	-10	As further discussed under Note 6 – Stock Options and Warrants, we recorded $61,480 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures.
	-11	As further discussed under Note 6 – Stock Options and Warrants, we recorded $0 for the computed fair value of warrants issued for services.
	-12	As further discussed under Note 6 – Stock Options and Warrants, we recorded $317,609 in connection for beneficial conversion features.
	-13	As further discussed under Note 6 – Stock Options and Warrants, we recorded $48,012 for deferred loan costs.



As of December 31, 2014 and 2013 we had 28,438,430 and 25,854,307 shares respectively, of common stock issued and outstanding.

Stock_Options_and_Warrants

Stock Options and Warrants	12 Months Ended
Stock Options and Warrants	Dec. 31, 2014
Stock Options and Warrants [Abstract]
STOCK OPTIONS AND WARRANTS	NOTE 5 - STOCK OPTIONS AND WARRANTS



	Equity Incentive Plans



	In April 2004, our Board of Directors and the stockholders at that time approved the adoption of a Voting Stock Option Plan (the “Plan”), which provides for the issuance of stock options to eligible employees, consultants, Board members and Advisory Board members of us to acquire up to a maximum of 5,000,000 shares of common stock.



	Our Board of Directors, which determines the number of options that will be granted, the effective dates of the grants, the option process and the vesting schedules, administers the Plan. In the absence of an established market for the common stock of the Company, the Board of Directors determines the fair market value of our common stock. Options generally expire between five and ten years from the date of grant and automatically terminate 90 days after such optionee ceases to be an eligible individual under the Plan other than by reason of death or disability.



	The portion of options granted that is not exercisable on the date the optionee ceases to be an eligible individual under the Plan by reason other than death, shall terminate and be forfeited to the Company on the date of such cessation. An optionee has no right as a stockholder with respect to any shares covered by the options granted to him until a certificate representing such shares is issued to them.



	Stock Options



	The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan during 2014 and 2013:



			Employee								Non-Employee
							Weighted								Weighted
			Number				Average				Number				Average				Combined
			Of				Exercise				Of				Exercise				Total
			Options				Price				Options				Price				Options
	Outstanding at December 31, 2012			1,440,916			$	0.38				18,180			$	1.15				1,459,096
	Granted			135,000				0.25				-				-				135,000
	Exercised			-				-				-				-				-
	Forfeited/Cancelled			(22,925	)			1.56				(2,280	)			2.5				(25,205	)
	Outstanding at December 31, 2013			1,552,991			$	0.35				15,900			$	2.5				1,568,891
	Granted			380,000				0.52				-				-				380,000
	Exercised			-				-				-				-				-
	Forfeited/Cancelled			(225,503	)			0.91				(15,900	)			2.5				(241,403	)
	Outstanding at December 31, 2014			1,707,488			$	0.31				-			$	-				1,707,488



	The following table summarizes information about those options that have been forfeited, cancelled or that have expired under the Plan during 2014 and 2013:



			Employee								Non-Employee
							Weighted								Weighted
			Number				Average				Number				Average				Combined
			Of				Exercise				Of				Exercise				Total
			Options				Price				Options				Price				Options

	Forfeited/Cancelled during FY 2013			(22,925	)		$	1.56				(2,280	)		$	2.5				(25,205	)

	Forfeited/Cancelled during FY 2014			(225,503	)		$	0.91				(15,900	)		$	2.5				(241,403	)

	Valuation Assumptions



	We value our stock-based payment awards granted using the Black-Scholes model, during the years ended December 31, 2014 and 2013. The Black-Scholes model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. The Black-Scholes model requires the input of certain assumptions that can vary over time. Our stock options have characteristics significantly different from those of traded options, and changes in the assumptions can materially affect the fair value estimates.



The risk-free interest rate is the implied yield currently available on the 5-year U.S. Treasury zero-coupon issues with a remaining term equal to the expected term. The expected term of the options was based on the simplified method outlined in ASC 718. The volatility factors were based on three peer companies selected from the Dow Jones U.S. Medical Equipment Index (^DJUSAM). These peer companies include companies which are the same market categories as the Company, which is the medical equipment and supplies line of business. The peer companies were selected based on similarity of industry characteristics, size and lifecycle characteristics. The calculated volatility value was established by taking the historical daily closing values prior to grant date, over a period equal to the expected term, for each of the peer companies, and then calculating a single average volatility.



For the years ended December 31, 2014 and 2013, respectively, the fair value of options granted were estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions:



		Equity Incentive
		Plans for
		Years Ended
		December 31,
		2014				2013

Expected terms (in years)			5-10				5-10
Volatility			83.79	%			40.45	%
Risk-free interest rate			0.82%-1.02	%			1.05%-1.74	%
Expected dividend rate			0	%			0	%



The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by optionees. We use historical volatility in deriving our expected volatility assumption because it believes that future volatility over the expected term of the stock options is not likely to differ from the past.



The expected dividend assumption is based on our history and expectation of dividend payouts. The fair value of the shares of common stock underlying the stock options has historically been determined by the board of directors. On or before February 2012, when our common stock commenced trading on the over the counter bulletin board (OTCQB), there has been no public market for our common stock. Consequently, the board of directors has historically determined the fair value of the common stock at the time of grant of the option by considering a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, amongst other factors.



FASB ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company only records stock-based compensation expense for awards that are expected to vest. While we generally consider historical forfeitures in its estimates, judgment is also required in estimating the amount of stock-based awards that are expected to be forfeited. The Company’s estimates for forfeitures may differ from actual forfeitures. If actual results differ significantly from these estimates, stock-based compensation expense and its results of operations could be materially impacted when the Company records a true-up for the difference in the period that the awards vest. We adjust stock-based compensation expense based on our actual forfeitures on an annual basis, if necessary.



Stock compensation cost, using the graded vesting attribute method in accordance with Codification topic 718, is recognized over the requisite service period, generally 5 years, during which each tranche of shares is earned (zero, one, two, three, and four years). The value of each tranche is generally amortized on a straight-line basis. For the years ended December 31, 2014 and 2013, stock based compensation expense was approximately $136,944 and $61,480, respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to employees. For the years ended December 31, 2014 and 2013, the number of options exercised was 0 for each year.



Compensation expense is recognized only for the portion of stock options that are expected to vest, assuming an expected forfeiture rate in determining stock-based compensation expense, which could affect the stock-based compensation expense recorded if there is a significant difference between actual and estimated forfeiture rates. As of December 31, 2014, total unrecognized compensation cost related to stock-based awards granted to employees and non-employee directors was $105,154. This cost will be amortized on a ratable basis over a weighted-average vesting period of approximately 1.18 years.



The following table summarizes information about employee stock options outstanding under the Plan at December 31, 2014:



31-Dec-14
		Options Outstanding												Options Exercisable
Range of Exercise Prices		Number				Weighted				Weighted				Number				Weighted				Weighted
		Outstanding				average				average				exercisable				average				average
						remaining				exercise price								remaining				exercise price
						contractual life												contractual life
$ 0.20 - $0.25			1,507,488				4.66			$	0.25				1,417,488				4.66			$	0.25
$ 0.50 - $1.00			200,000				4.57			$	0.89				87,500				3.86			$	0.74
			1,707,488												1,504,988



There were no non-employee stock options outstanding or exercisable at December 31, 2014.



Warrants.



The following table summarizes our warrant activities for the years ended December 31, 2014 and 2013:



								Weighted
				Number				Average
				Of				Exercise				Estimated				Intrinsic
				Warrants				Price				Life (Years)				Value
	Outstanding at December 31, 2012				1,877,034			$	0.8				1.65			$	1.07
	Granted				1,576,364			$	1.44				4.3			$	-
	Exercised				(438,889	)			0.01
	Forfeited/Cancelled				(47,500	)			0.69
	Exercisable				2,967,009			$	1.13				2.81			$	0.19
	Outstanding at December 31, 2013				2,967,009			$	1.13				2.81			$	0.19
	Granted				1,467,896			$	1.26				3.95			$	-
	Exercised				(436,945	)			0.01
	Forfeited/Cancelled				(468,700	)			0.65
	Exercisable				3,569,260			$	1.37				3.18			$	-
	Outstanding at December 31, 2014				3,569,260			$	1.37				3.18			$	-

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
INCOME TAXES	NOTE 6 - INCOME TAXES



	The Company adopted the provisions of ASC 740, “Accounting for Uncertainty in Income Taxes,” on January 1, 2008. FASB ASC Topic 740 clarifies the accounting for income taxes by prescribing a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. FASB ASC Topic 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of FASB ASC Topic 740, the Company did not recognize a decrease or increase in the liability for unrecognized tax benefits.



	As of December 31, 2014 and 2013, the Company had cumulative net operating loss carry-forwards of approximately $15,150,126 and $12,146,279 respectively, which expire in varying amounts between 2024 and 2034. Realization of this potential future tax benefit is dependent on generating sufficient taxable income prior to expiration of the loss carry-forward. The deferred tax asset related to this (and other) potential future tax benefits has been offset by a valuation allowance in the same amount. The amount of the deferred tax asset ultimately realizable could be increased in the near term if estimates of future taxable income during the carry-forward period are revised.



	Deferred income tax assets of $5,588,365 and $4,733,483 for the years December 31, 2014 and 2013 respectively were offset in full by a valuation allowance.



	The components of the Company's net deferred tax assets, including a valuation allowance, for the years 2014 and 2013 are as follows:



	Deferred Tax Assets	As of			As of December 31, 2013
		December 31, 2014
	Net operating loss carry-forwards	$	5,150,797		$	4,129,735

	Net deferred tax assets before valuation allowance	$	5,588,365		$	4,733,483
	Less: Valuation Allowance	$	(5,588,365	)	$	(4,733,483	)
	Net deferred tax assets		--			--



	Reconciliation between the amounts of income tax benefit determined by applying the applicable U.S. income tax rate to pre-tax loss is as follows:



		As of December 31, 2014			As of
					December 31, 2013
	Statutory federal income tax		34	%		34	%
	Statutory state income tax		(0.22	%)		(0.92	%)
	Change in valuation allowance on deferred tax assets		(33.51	%)		(33.69	%)
	Net effective tax rate		(0.27	%)		(0.61	%)



	Due to the inherent uncertainty in forecasts and future events and operating results, the Company has provided for a valuation allowance in an amount equal to gross deferred tax assets resulting in the above figures for the periods audited.

License_and_Service_Agreements

License and Service Agreements	12 Months Ended
License and Service Agreements	Dec. 31, 2014
License and Service Agreements [Abstract]
LICENSE AND SERVICE AGREEMENTS	NOTE 7 – LICENSE AND SERVICE AGREEMENTS



	There were no material service agreements during 2014.

Commitments_and_Contingency

Commitments and Contingency	12 Months Ended
	Dec. 31, 2014
Commitments and Contingency [Abstract]
COMMITMENTS AND CONTINGENCY	NOTE 8 – COMMITMENTS AND CONTINGENCY



	Leases



	Operating Lease – During 2007, we entered into a long-term non-cancelable lease for office space, which expired in October 2012. On December 31, 2013 we extended this lease until December 31, 2017.



	At December 31, 2014, future minimum lease payments under the non-cancelable operating lease for the year ended December 31, 2014 were as follows:



	2015	$	194,400
	2016		210,600
	2017		210,600
	Thereafter		-
		$	615,600



	Rental expense for the years ended December 31, 2014 and 2013 was $194,400 and $194,400, respectively.



	Capital lease – During 2014 we retired our master lease agreement with a VenCore Solutions, LLC (“Vencore”). The Vencore lease had a balance of $307,662 which we settled in full through the payment of $150,000 in cash and 75,000 shares of common stock. The balance on the Vencore lease at December 31, 2014 was $0.



	Minimum non-cancellable lease payments required under all capital leases as at December 31, 2014 are as follows:



	2014		149
	Thereafter		-
		$	149

	Legal Proceedings



	The Company is subject to litigation in the normal course of business, none of which management believes will have a material adverse effect on the Company’s financial statements.



	On or about December 13 of 2013, Wall Street Buy Sell Hold, Inc., (“WSBSH”) filed a lawsuit against the Company in the New York Supreme Court, Nassau County. The suit seeks damages in the form of money, stock and warrants for breach of a marketing agreement entered into on October 22, 2012 and another entered into on March 11, 2013. We have answered the complaint and filed a counterclaim against WSBSH seeking the return of all moneys and shares we paid or transferred to WSBSH, as well as punitive damages for fraud. We have entered the discovery phase in this matter. Management believes the WSBSH claims have no merit, and we intend to vigorously defend our interests in this matter.



	Indemnification



	Under the indemnification provisions of our customer agreements, we routinely agree to indemnify and defend our customers against infringement of any patent, trademark, or copyright of any country or the misappropriation of any trade secret, arising from the customers’ legal use of our products or services. The exposure to us under these indemnification provisions is generally limited to the total amount paid by the customers under pertinent agreements. However, certain indemnification provisions potentially expose us to losses in excess of the aggregate amount received from the customer. To date, there have been no claims against us or our customers pertaining to such indemnification provisions and no amounts have been recorded.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2014
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS



	A summary of the related party financings and notes payable to related parties as at December 31, 2014 is as follows:



			Shareholder advances
	Holder		Julian Ross(1)			Other
	Amount		$	154,850		$	-
	Stated interest rate			0	%		0	%
	Maturity			n/a			n/a



	A summary of the related party financings and notes payable to related parties as at December 31, 2013 is as follows:



			Shareholder advances
	Holder		Julian Ross(1)			Other
	Amount		$	118,627		$	-
	Stated interest rate			0	%		0	%
	Maturity			n/a			n/a



	-1	Our CEO, Mr. Ross provided us cash and other consideration from time to time to fund to fund working capital. The net amounts outstanding to Mr. Ross were $154,850 and $118,627 as at December 31, 2014 and December 31, 2013, respectively.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2014
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 10 – FAIR VALUE MEASUREMENTS



	Effective January 1, 2009, the Company adopted new fair value accounting guidance. The adoption of the guidance was limited to financial assets and liabilities and did not have a material effect on our financial condition or results of operations.



	The guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact business and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. The guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The guidance establishes three levels of inputs that may be used to measure fair value:



	Level 1 — Quoted prices in active markets for identical assets or liabilities.



	Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.



	Level 3 — Unobservable inputs to the valuation methodology that is significant to the measurement of fair value of assets or liabilities.



	Changes related to derivatives for the year ended December 31, 2014 are as follows:



		Derivative
		Liabilities

	Balance as of December 31, 2013	$	-
	Additions related to embedded derivative of convertible notes issued		28,009
	Gain on decrease in value of derivative liabilities		3,001
	Balance as of December 31, 2014	$	31,010

Off_Balance_Sheet_Arrangements

Off Balance Sheet Arrangements and Contractual Obligations	12 Months Ended
Off Balance Sheet Arrangements and Contractual Obligations	Dec. 31, 2013
Off Balance Sheet Arrangements and Contractual Obligations [Abstract]
OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS	NOTE 11 – OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS



	We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.

Segment_Information

Segment Information	12 Months Ended
	Dec. 31, 2014
Segment Information [Abstract]
SEGMENT INFORMATION	NOTE 12 – SEGMENT INFORMATION



	We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products and accessories. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.



	The following presents total revenue by geographic region:



		Year Ended
		December 31,
		2014		2013
	Revenues:
	United States revenues	$	2,380,000	$	1,302,042
	ROW revenues		57,402		498,286
	Totals	$	2,437,402	$	1,800,327

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2014
Going Concern [Abstract]
GOING CONCERN	NOTE 13 – GOING CONCERN



	Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. We have been suffering from recurring losses from operations. Our total notes payable has increased to $723,323 at December 31, 2014 from $349,975 at December 31, 2013. Our current notes payable has also increased to $678,839 at December 31, 2014 from $273,903 at December 31, 2013. Our long term notes payable decreased from $76,072 for December 31, 2013 to $44,484 at December 31, 2014.



	Our continuation as a going concern is dependent upon our ability to generate sufficient cash flow from operations to meet our obligations on a timely basis and/or obtain financing as may be required. For the years ended December 31, 2014 and 2013 we have incurred net losses from operations of $1,099,349 and $860,791, respectively. As of December 31, 2014 and 2013, we have accumulated stockholders’ deficits of $18,041,208 and $15,287,647, respectively, since inception. We had a working capital surplus of $418,734 as of December 31, 2014 and a working capital surplus of $747,473 as of December 31, 2013. While our revenues have increased significantly from 2013 to 2014, we are still in the early stages of the commercialization or our primary product, and we currently operate in a single industry segment. These factors raise significant doubt about our ability to continue as a going concern.



	During the next 12 months, our foreseeable cash requirements will relate to continual development of the operations of our business, maintaining our good standing and making the requisite filings with the Securities and Exchange Commission, and the payment of expenses associated with reviewing or investigating any potential business ventures. We may experience a cash shortfall and may be required to raise additional capital. Historically, we have relied upon internally generated funds and funds from the sale of shares of stock and loans and advances from our shareholders and private investors to finance our operations and growth. We may raise additional capital through future public or private offerings of our stock or through loans from investors, although there can be no assurance that we will be able to obtain such financing. Our failure to do so could have a material and adverse effect upon us and our shareholders.



	We have a series of plans to mitigate the going concern:



	1.	Management is seeking additional sources of equity and/or debt financing on terms that are reasonable for us; however, there is no assurance that any such additional funding will be available.



	2.	We anticipate that sales during 2015 and 2016 from existing markets will grow, and we believe that we will be able to generate sales from new markets. Existing markets include education customers such as schools, school districts and colleges, and commercial customers such as manufacturing facilities, churches and other commercial venues. New markets will include, but not be limited to, government customers and new international territories and markets.



	3.	We plan to increase our market penetration through the addition of new distributors, both in the US and outside the US during 2015 and beyond. We also plan to increase the number direct sales territory managers we will appoint in the U.S. to sell our products.



	4.	We plan to continue to diversify our product range through the addition of complementary products and solutions. Some of these products will be sourced from third party manufacturers and suppliers.



	5.	We may seek or consider strategic business combinations with other companies to complement our resources and create synergies.

Concentration_of_Risk_in_Custo

Concentration of Risk in Customer and Supplier Relationships	12 Months Ended
	Dec. 31, 2014
Concentration of Risk in Customer and Supplier Relationships [Abstract]
CONCENTRATION OF RISK IN CUSTOMER AND SUPPLIER RELATIONSHIPS	NOTE 14 – CONCENTRATION OF RISK IN CUSTOMER AND SUPPLIER RELATIONSHIPS



	Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. At times, cash account balances may be in excess of the amounts insured by the Federal Deposit Insurance Corporation (FDIC). However, management believes the risk of loss to be minimal. The Company performs periodic evaluations of the relative credit standing of these institutions and has not experienced any losses on its cash and cash equivalents and short-term investments to date.



	The relative magnitude and the mix of revenue from our largest customers have varied significantly from quarter to quarter. During the twelve months ended December 31, 2014 and 2013, the following customers have accounted for significant revenues, varying by period, to our company: Knight Aerospace, Inc., and PP Aviation Corporation. For the twelve months ended December 31, 2014 and 2013, the percentages of revenues from our largest two customers are as follows:



		Year Ended
		December 31,
		2014			2013

	Knight Aerospace, Inc.		58	%		35	%
	PP Aviation Corporation		19	%		28	%



	Over time, as we work to add additional distributors to our network and to grow our distribution business, we anticipate the relative significance to our revenue of any particular customer or distributor will decline.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 15 - SUBSEQUENT EVENTS



	The Company has evaluated events and transactions subsequent to December 31, 2014 through the date of issuance of the Financial Statements. During the period from January 1, 2015 to the date of issuance, we have had the following material subsequent events:



	Re-appointment of Julian T. Ross as Chairman & CEO:



	On January 12, 2015, our Board of Directors re-appointed Julian T. Ross as our Chairman and Chief Executive Officer, a position he has held since the Company’s inception. We entered into a third employment agreement (“Agreement”) between us and Mr. Ross. Mr. Ross will also continue to serve as our Chief Financial Officer and Secretary until such time as we completes this hire(s).



	The Agreement has an effective date of January 1, 2015 and its summary terms include, but are not limited to the following:



	Term:	Three (3) years
	Base Salary:	$275,000 per annum payable twice monthly
	Annual Bonus:	40% of Base Salary, provided that: (i) 30% of the Annual Bonus is subject to achievement of MBOs (Management by Objectives) determined by the Board; (ii) 70% of the Annual Bonus is subject to achievement of financial performance metrics set by the Board (for example, Revenue or Revenue Growth, Stock Price, and so forth).
	Stock Options:	Stock options valued at $200,000 per annum with exercise price at market price
	Restricted Stock Units:	(i) Base Restricted Stock Units (“RSUs”): $100,000 per year; Up to an additional $200,000 per year at the Board’s sole and absolute discretion. (ii) Performance Restricted Stock Units: 150,000 units subject to achieving both positive net earnings and positive EBITDA for a 6 month period (one time issuance).



	Stock issuances:



	We issued 318,349 shares of common stock pursuant to the cashless conversion of 170 shares of Series B Preferred; we issued 58,000 shares of our common stock in connection with an investment banking agreement; we issued 602,426 shares of common stock pursuant to the cashless, partial conversions of convertible notes; and we issued 30,000 shares of our common stock in connection with a licensing and marketing agreement.

Organization_and_Summary_of_Si1

Organization and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Organization and Summary of Significant Accounting Policies [Abstract]
Basis of Presentation

	Basis of Presentation - Management acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company’s system of internal accounting control is designed to assure, among other items, that (1) recorded transactions are valid; (2) all valid transactions are recorded; and (3) transactions are recorded in the period in a timely manner to produce financial statements which present fairly the financial condition of the Company.

Use of estimates

	Use of estimates - The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimated.

Revenue Recognition	Revenue Recognition - We recognize revenue when persuasive evidence of an arrangement exists, shipment has occurred, the price is fixed or determinable, and collectability is reasonably assured. Revenues are recognized from product sales, net of discounts and rebates. This revenue recognition policy is applied to both customers and distributors.



	Fees from licensees desiring to manufacture and distribute our products or derivative products using our intellectual property include initial license fees and royalties. Initial license fees are generally recognized upon granting of the license to the licensee. Royalties are recognized in the period earned.

Deferred Revenue and Income	Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was and $0 and $2,976 for the years ended December 31, 2014 and 2013 respectively.

Cash and Cash Equivalents	Cash and Cash Equivalents - Cash consists of all highly liquid investments purchased with maturity of three months or less to be cash equivalents. Cash and cash equivalents may at times exceed Federally-insured limits. To minimize this risk, we place our cash and cash equivalents with high credit quality institutions.

Inventories	Inventories – Our inventories consist of raw material and components for our portable oxygen systems as well as completed products and accessories. Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer. We write down our inventory value for estimated obsolescence equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. These factors are impacted by market and economic conditions, technology changes, new product introductions and changes in strategic direction and require estimates that may include uncertain elements. Actual demand may differ from forecasted demand, and such differences may have a material effect on recorded inventory values. Management has established inventory reserves to cover estimated inventory losses for all work-in-process and finished goods related to products we manufactured, as well as raw material and components for those products that had no potential use in products to be manufactured in the future. Management is required to make judgments about the future benefit of our raw materials and components. Actual reserve requirements could differ significantly from Management’s estimates, which could have a significant unfavorable impact on our future gross margins.



	At December 31, 2014 and December 31, 2013 inventories consisted of the following:



		December 31,
		2014			2013
	Raw materials	$	133,477		$	145,827
	Work in process		41,114			78,809
	Finished goods		102,755			63,030

		$	277,346		$	287,666



Concentration of Credit Risk	Concentration of Credit Risk – We sell our products throughout the United States as well as in certain other countries. Sales to its recurring customers in the United States are generally granted on net 30-day credit terms. We perform periodic credit evaluations of our recurring customers and generally do not require collateral. In general, we require prepayment on all sales to customers outside the United States. An allowance for doubtful accounts is maintained for potential credit losses, which losses historically have not been significant.



	We invest our cash in deposits and money market funds with major financial institutions. We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

Fair Value of Financial Instruments	Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable. We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:



	Level 1: Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

	Level 2: Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

	Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.



	The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

Property and Equipment	Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years. Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms. Depreciation expense was $11,970 and $23,165 for the years ended December 31, 2014 and 2013, respectively.



	Property and equipment consist of the following:



		December 31,
		2014			2013

	Leasehold Improvements		547,856			547,856
	Machinery and equipment on capital leases		919,736			919,736
	Property, plant and equipment		237,484			196,051
	Furniture and fixtures		34,821			16,254
	Computers and software		55,368			47,288

			1,795,265			1,727,185

	Less: accumulated depreciation		(1,703,727	)		(1,656,936	)

			91,537			70,249
Other Long-Lived Assets	Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization.



	Amortization expense for patents and trademarks was $30,180 and $29,995 for the years ended December 31, 2014 and 2013, respectively.



	Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified. Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. Certain events and circumstances we considered in determining whether the carrying value of identifiable intangible assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in its business strategy. In determining if impairment exists, we estimate the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the years ended December 31, 2014 and 2013.

Other assets	Other Assets – We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $92,612 and $102,404 for the years ended December 31, 2014 and 2013, respectively.



	Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.

Allowance for Doubtful Accounts	Allowance for Doubtful Accounts - We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make payments. We periodically review these allowances, including an analysis of the customers’ payment history and information regarding the customers’ creditworthiness. Actual write-offs have not been materially different from the estimated allowance. We recorded bad debt expense of $2,443 and $23,194 for the years ended December 31, 2014 and 2013, respectively.

Research and Development Costs	Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred. $583,435 and $356,015 were incurred in the years ended December 31, 2014 and 2013, respectively.

Income taxes

	Income Taxes – In accordance with Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes” (“ASC 740”), we account for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our Consolidated Financial Statements, but have not been reflected in our taxable income. A valuation allowance has been established to reduce deferred tax assets to their estimated realizable value. Therefore, we provide a valuation allowance to the extent that we do not believe it is more likely than not that we will generate sufficient taxable income in future periods to realize the benefit of our deferred tax assets. We recognize interest and penalties related to unrecognized tax benefits in income tax expense.

Stock-Based Compensation	Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties. We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model, which was developed for use in estimating the value of traded options that have no vesting restrictions and that are freely transferable. The Black-Scholes model requires the input of certain assumptions. Changes in the assumptions used in Black-Scholes model can materially affect the fair value estimates. We evaluate the assumptions used to value stock options on an annual basis. The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding.



	The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by employees. Upon the adoption of the accounting guidance, we continued to use historical volatility in deriving the expected volatility assumption as allowed under GAAP because we believe that future volatility over the expected term of the stock options is not likely to differ materially from the past. The risk-free interest rate assumption is based on 5-year U.S Treasury zero-coupon rates appropriate for the expected term of the stock options. The expected dividend assumption is based on the history and expectation of dividend payouts. The fair values generated by the Black-Scholes model may not be indicative of the actual fair values of the equity awards, as we do not consider other factors important to those awards to employees, such as continued employment, periodic vesting requirements and limited transferability. The amount of stock based compensation expenses is net of an estimated forfeiture rate, which is also based on historical data. For the years ended December 31, 2014 and 2013, stock based compensation expense was approximately $136,944 and $61,480 respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to the employees.



	The Company follows ASC Topic 505-50, formerly EITF 96-18, “Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling Goods and Services,” for stock options and warrants issued to consultants and other non-employees. In accordance with ASC Topic 505-50, these stock options and warrants issued as compensation for services to be provided to the Company are accounted for based upon the fair value of the services provided or the estimated fair market value of the option or warrant, whichever can be more clearly determined. We recognize this expense over the period in which the services are provided. For the years ended December 31, 2014 and 2013, stock based compensation expense was approximately $0 in each year, which consisted primarily of stock-based compensation expense related to stock options and warrants recognized under GAAP issued to consultants and other non-employees.



	The following table shows the components of our stock based compensation expense for employees, consultants and other non-employees:



		Year ended
		December 31,
		2014			2013

	Common Stock options issued for compensation	$	108,244		$	61,480
	Common Stock options and warrants issued for services		28,700			-

	Total	$	136,944		$	61,480
Shipping and Handling Costs	Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

Advertising Costs

	Advertising Costs - Advertising costs are charged to operations when incurred. During the years ended December 31, 2014 and 2013 we incurred $718,705 and $353,156 respectively, in advertising and promotion costs.

Litigation and Settlement Costs

	Litigation and Settlement Costs - Legal costs are expensed as incurred. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) accrue the best estimate within a range of loss if there is a loss or, when there is no amount within a range that forms a better estimate, we will accrue the minimum amount in the range.

Loss Per Share	Loss Per Share - Basic loss per share, which excludes anti-dilutive securities, is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding for that particular period. In contrast, diluted loss per share considers the potential dilution that could occur from other equity instruments that would increase the total number of outstanding shares of common stock. Such amounts include shares potentially issuable under outstanding options, warrants, convertible preferred stock and convertible notes.



	A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share follows:



		Year ended
		December 31,
		2014			2013
	Historical net loss per share:

	Numerator
	Net loss, as reported		(2,753,560	)		(712,452	)
	Less: Effect of amortization of interest expense on convertible notes		-			-
	Net loss attributed to common stockholders (diluted)		(2,753,560	)		(712,452	)

	Denominator
	Weighted-average common shares outstanding		26,406,409			23,754,402
	Effect of dilutive securities		-			-
	Denominator for diluted net loss per share		26,406,409			23,754,402
	Basic and diluted net loss per share	$	(0.10	)	$	(0.03	)

	Basic and Diluted Loss per Share:



	The computation of basic earnings per share of common stock is based on the weighted average number of shares outstanding during the periods presented. The computation of fully diluted earnings per share includes common stock equivalents outstanding at the balance sheet date. The Company had 3,757,583 and 1,635,694 stock options, warrants and convertible note shares that would have been included in the fully diluted earnings per share as of December 31, 2014 and 2013, respectively. However, the common stock equivalents were not included in the computation of the loss per share computation because they are anti-dilutive.
Reclassifications

	Reclassifications - Certain financial statement items have been reclassified to conform to the current year’s presentation.

Recent Accounting Pronouncements	Recent Accounting Pronouncements



	We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

Organization_and_Summary_of_Si2

Organization and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Organization and Summary of Significant Accounting Policies [Abstract]
Schedule of inventories

		December 31,
		2014			2013
	Raw materials	$	133,477		$	145,827
	Work in process		41,114			78,809
	Finished goods		102,755			63,030

		$	277,346		$	287,666
Summary of property and equipment

		December 31,
		2014			2013

	Leasehold Improvements		547,856			547,856
	Machinery and equipment on capital leases		919,736			919,736
	Property, plant and equipment		237,484			196,051
	Furniture and fixtures		34,821			16,254
	Computers and software		55,368			47,288

			1,795,265			1,727,185

	Less: accumulated depreciation		(1,703,727	)		(1,656,936	)

			91,537			70,249
Schedule of stock based compensation expense		Year ended
		December 31,
		2014			2013

	Common Stock options issued for compensation	$	108,244		$	61,480
	Common Stock options and warrants issued for services		28,700			-

	Total	$	136,944		$	61,480
Schedule of numerator and denominator used in calculation of basic and diluted net loss per share		Year ended
		December 31,
		2014			2013
	Historical net loss per share:

	Numerator
	Net loss, as reported		(2,753,560	)		(712,452	)
	Less: Effect of amortization of interest expense on convertible notes		-			-
	Net loss attributed to common stockholders (diluted)		(2,753,560	)		(712,452	)

	Denominator
	Weighted-average common shares outstanding		26,406,409			23,754,402
	Effect of dilutive securities		-			-
	Denominator for diluted net loss per share		26,406,409			23,754,402
	Basic and diluted net loss per share	$	(0.10	)	$	(0.03	)

Intangible_Assets_Tables

Intangible Assets (Tables)	12 Months Ended
Intangible Assets (Tables)	Dec. 31, 2014
Intangible Assets [Abstract]
Summary of carrying values of amortized acquired intangible assets		31-Dec-14							31-Dec-13
		Gross		Accumulated Amortization and write off			Net		Gross		Accumulated Amortization and write off			Net

	Patents	$	618,150	$	(287,662	)	$	330,488	$	617,651	$	(260,171	)	$	357,480
	Trademarks	$	45,723	$	(13,447	)	$	32,276	$	45,723	$	(10,758	)	$	34,965
		$	663,873	$	(301,109	)	$	362,764	$	663,374	$	(270,929	)	$	392,445
Summary of estimated future amortization expense of intangible assets	2015	$	30,232
	2016		30,232
	2017		30,232
	2018		30,232
	Thereafter		241,837
		$	362,764

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
Notes Payable (Tables)	Dec. 31, 2014
Debt Instrument [Line Items]
Carrying values of short-term and long-term notes payable

		Effective Interest Rate			Principal		Accrued Interest		Discount		December 31,
		Effective Interest Rate			Principal		Accrued Interest		Discount		2014

	Current notes payable
	Iliad Trading and Research Notes		1.5	%		157,458		2,346		-		159,804
	Union Capital Funding Notes		69.9	%		297,000		4,680		202,843		98,837
	JSJ Investments Notes		37.3	%		300,000		10,685		101,124		209,561
	Sojourn Note		92.9	%		30,000		819		27,041		3,778
	WHC Capital Note		74.5	%		38,500		405		28,293		10,612
	Group 10 Notes		64.3	%		236,000		2,716		148,963		89,753
	GEL Notes		66.8	%		165,000		1,465		108,761		57,704
	Frisco EDC		12.3	%		104,000		-		15,516		88,484

	Total short-term notes payable				$	1,327,958	$	23,116	$	632,542	$	718,533

	Long-term notes payable
	none				$	-		-		-	$	0

	Total long-term notes payable				$	0	$	0	$	0	$	0
	Total short-term and long-term notes payable				$	1,327,958	$	23,116	$	632,541	$	718,533





		Effective Interest Rate			Principal		Accrued Interest		Discount		December 31,
		Effective Interest Rate			Principal		Accrued Interest		Discount		2013

	Current notes payable
	Iliad Trading and Research Notes		47.3	%		165,000		5,004		72,980		97,024
	LG Capital Funding		53.7	%		57,500		3,008		27,886		32,622
	JMJ Financial		70.4	%		110,000		13,200		64,195		59,005
	Tonaquint, Inc.		47	%		105,000		6,785		42,535		69,250
	Frisco EDC		12.34	%		44,000		-		-		44,000

	Total short-term notes payable				$	481,500	$	27,997	$	207,596	$	301,901

	Long-term notes payable
	Frisco EDC		12.34	%	$	104,000		-		27,928	$	76,072

	Total long-term notes payable				$	104,000	$	0	$	27,928	$	76,072
	Total short-term and long-term notes payable				$	585,500	$	27,997	$	235,524	$	377,973
Schedule of aggregate maturities of debt

		As of
		December 31,
		2014

	2015	$	718,533
	Thereafter		-
	Total	$	718,533
Frisco EDC [Member]
Debt Instrument [Line Items]
Future principal payments of Frisco note payable	2015		52,000
	2016		52,000
		$	104,000

Stock_Options_and_Warrants_Tab

Stock Options and Warrants (Tables)	12 Months Ended
Stock Options and Warrants (Tables)	Dec. 31, 2014
Stock Options and Warrants [Abstract]
Summary of option activity


			Employee								Non-Employee
							Weighted								Weighted
			Number				Average				Number				Average				Combined
			Of				Exercise				Of				Exercise				Total
			Options				Price				Options				Price				Options
	Outstanding at December 31, 2012			1,440,916			$	0.38				18,180			$	1.15				1,459,096
	Granted			135,000				0.25				-				-				135,000
	Exercised			-				-				-				-				-
	Forfeited/Cancelled			(22,925	)			1.56				(2,280	)			2.5				(25,205	)
	Outstanding at December 31, 2013			1,552,991			$	0.35				15,900			$	2.5				1,568,891
	Granted			380,000				0.52				-				-				380,000
	Exercised			-				-				-				-				-
	Forfeited/Cancelled			(225,503	)			0.91				(15,900	)			2.5				(241,403	)
	Outstanding at December 31, 2014			1,707,488			$	0.31				-			$	-				1,707,488


Summary of options forfeited/cancelled

			Employee								Non-Employee
							Weighted								Weighted
			Number				Average				Number				Average				Combined
			Of				Exercise				Of				Exercise				Total
			Options				Price				Options				Price				Options

	Forfeited/Cancelled during FY 2013			(22,925	)		$	1.56				(2,280	)		$	2.5				(25,205	)

	Forfeited/Cancelled during FY 2014			(225,503	)		$	0.91				(15,900	)		$	2.5				(241,403	)
Summary of assumptions to estimate the fair value of options granted			Equity Incentive
			Plans for
			Years Ended
			December 31,
			2014				2013

	Expected terms (in years)			5-10				5-10
	Volatility			83.79	%			40.45	%
	Risk-free interest rate			0.82%-1.02	%			1.05%-1.74	%
	Expected dividend rate			0	%			0	%


Summary of employee stock options outstanding under the Plan


	31-Dec-14
			Options Outstanding												Options Exercisable
	Range of Exercise Prices		Number				Weighted				Weighted				Number				Weighted			Weighted
			Outstanding				average				average				exercisable				average			average
							remaining				exercise price								remaining			exercise price
							contractual life												contractual life
	$ 0.20 - $0.25			1,507,488				4.66			$	0.25				1,417,488				4.66		$	0.25
	$ 0.50 - $1.00			200,000				4.57			$	0.89				87,500				3.86		$	0.74
				1,707,488												1,504,988


Summary of warrant activity									Weighted
					Number				Average
					Of				Exercise				Estimated				Intrinsic
					Warrants				Price				Life (Years)				Value
		Outstanding at December 31, 2012				1,877,034			$	0.8				1.65			$	1.07
		Granted				1,576,364			$	1.44				4.3			$	-
		Exercised				(438,889	)			0.01
		Forfeited/Cancelled				(47,500	)			0.69
		Exercisable				2,967,009			$	1.13				2.81			$	0.19
		Outstanding at December 31, 2013				2,967,009			$	1.13				2.81			$	0.19
		Granted				1,467,896			$	1.26				3.95			$	-
		Exercised				(436,945	)			0.01
		Forfeited/Cancelled				(468,700	)			0.65
		Exercisable				3,569,260			$	1.37				3.18			$	-
		Outstanding at December 31, 2014				3,569,260			$	1.37				3.18			$	-

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2014
Income Taxes [Abstract]
Summary of components of net deferred tax assets including valuation allowance	Deferred Tax Assets	As of			As of December 31, 2013
	Deferred Tax Assets	December 31, 2014			As of December 31, 2013
	Net operating loss carry-forwards	$	5,150,797		$	4,129,735

	Net deferred tax assets before valuation allowance	$	5,588,365		$	4,733,483
	Less: Valuation Allowance	$	(5,588,365	)	$	(4,733,483	)
	Net deferred tax assets		--			--

Schedule of reconciliation of income tax rate to pre-tax loss		As of December 31, 2014			As of
		As of December 31, 2014			December 31, 2013
	Statutory federal income tax		34	%		34	%
	Statutory state income tax		(0.22	%)		(0.92	%)
	Change in valuation allowance on deferred tax assets		(33.51	%)		(33.69	%)
	Net effective tax rate		(0.27	%)		(0.61	%)

Commitments_and_Contingency_Ta

Commitments and Contingency (Tables)	12 Months Ended
Commitments and Contingency (Tables)	Dec. 31, 2014
Commitments and Contingency [Abstract]
Summary of future minimum lease payments under non-cancelable operating lease

	2015	$	194,400
	2016		210,600
	2017		210,600
	Thereafter		-
		$	615,600
Summary of minimum non-cancellable lease payments required under capital leases

	2014		149
	Thereafter		-
		$	149

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	12 Months Ended
Related Party Transactions (Tables)	Dec. 31, 2014
Related Party Transactions [Abstract]
Summary of the related party financings and notes payable			Shareholder advances
	Holder		Julian Ross(1)			Other
	Amount		$	154,850		$	-
	Stated interest rate			0	%		0	%
	Maturity			n/a			n/a



	A summary of the related party financings and notes payable to related parties as at December 31, 2013 is as follows:



			Shareholder advances
	Holder		Julian Ross(1)			Other
	Amount		$	118,627		$	-
	Stated interest rate			0	%		0	%
	Maturity			n/a			n/a



	-1	Our CEO, Mr. Ross provided us cash and other consideration from time to time to fund to fund working capital. The net amounts outstanding to Mr. Ross were $154,850 and $118,627 as at December 31, 2014 and December 31, 2013, respectively.

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2014
Fair Value Measurements [Abstract]
Schedule of derivative liabilities at fair value measurement		Derivative
		Liabilities

	Balance as of December 31, 2013	$	-
	Additions related to embedded derivative of convertible notes issued		28,009
	Gain on decrease in value of derivative liabilities		3,001
	Balance as of December 31, 2014	$	31,010

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2014
Segment Information [Abstract]
Components of revenue by geographic region		Year Ended
		December 31,
		2014		2013
	Revenues:
	United States revenues	$	2,380,000	$	1,302,042
	ROW revenues		57,402		498,286
	Totals	$	2,437,402	$	1,800,327

Concentration_of_Risk_in_Custo1

Concentration of Risk in Customer and Supplier Relationships (Tables)	12 Months Ended
	Dec. 31, 2014
Concentration of Risk in Customer and Supplier Relationships [Abstract]
Summary of percentages of revenues from customers		Year Ended
		December 31,
		2014			2013

	Knight Aerospace, Inc.		58	%		35	%
	PP Aviation Corporation		19	%		28	%

Organization_and_Summary_of_Si3

Organization and Summary of Significant Accounting Policies (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of Inventories
Raw materials	$133,477	$145,827
Work in process	41,114	78,809
Finished goods	102,755	63,030
Total inventories	$277,346	$287,666

Organization_and_Summary_of_Si4

Organization and Summary of Significant Accounting Policies (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of property and equipment
Leasehold Improvements	$547,856	$547,856
Machinery and equipment on capital leases	919,736	919,736
Property, plant and equipment	237,484	196,051
Furniture and fixtures	34,821	16,254
Computers and software	55,368	47,288
Property and equipment, gross	1,795,265	1,727,185
Less: accumulated depreciation	-1,703,727	-1,656,936
Total property and equipment, net	$91,537	$70,249

Organization_and_Summary_of_Si5

Organization and Summary of Significant Accounting Policies (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Schedule of stock based compensation expense
Common Stock options issued for compensation	$108,244	$61,480
Common Stock options and warrants issued for services	28,700
Total	$136,944	$61,480

Organization_and_Summary_of_Si6

Organization and Summary of Significant Accounting Policies (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Numerator
Net loss, as reported	($2,753,560)	($712,452)
Less: Effect of amortization of interest expense on convertible notes
Net loss attributed to common stockholders (diluted)	($2,753,560)	($712,452)
Denominator
Weighted-average common shares outstanding	26,367,254	23,754,402
Effect of dilutive securities
Denominator for diluted net loss per share	26,367,254	23,754,402
Basic and diluted net loss per share	($0.10)	($0.03)

Organization_and_Summary_of_Si7

Organization and Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
	Patent	Dec. 31, 2013
Summary of Significant Accounting Policies (Textual)
Number of issued patents owned by company	7
Deferred revenue		$2,976
Credit period granted to recurring customers on sales		30 days
Depreciation expense	11,970	23,165
Amortization of intangible assets	30,180	29,995
Impairment charges for patents	0	0
Amortization expense of other assets	92,612	102,404
Bad debts expenses	2,443	23,194
Research and development expense	583,435	356,015
Stock-based compensation expense related to stock options issued to the employees	108,244	61,480
Common Stock options and warrants issued for services	28,700
Advertising and promotion costs	$718,705	$353,156
Stock options, warrants and convertible note shares excluded from computation of the loss per share	3,757,583	1,635,694
Furniture and Fixtures [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	5 years
Software [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	3 years
Software [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	3 years
Software [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	5 years
Machinery and Equipment [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	5 years
Machinery and Equipment [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	7 years
Leasehold Improvements [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	3 years
Leasehold Improvements [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life	7 years

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of carrying values of amortized acquired intangible assets
Intangible assets, Gross	$663,873	$663,374
Intangible assets, Accumulated Amortization and write off	-301,109	-270,929
Intangible assets, Net	362,764	392,445
Patents [Member]
Summary of carrying values of amortized acquired intangible assets
Intangible assets, Gross	618,150	617,651
Intangible assets, Accumulated Amortization and write off	-287,662	-260,171
Intangible assets, Net	330,488	357,480
Trademarks [Member]
Summary of carrying values of amortized acquired intangible assets
Intangible assets, Gross	45,723	45,723
Intangible assets, Accumulated Amortization and write off	-13,447	-10,758
Intangible assets, Net	$32,276	$34,965

Intangible_Assets_Details_1

Intangible Assets (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of estimated future amortization expense of intangible assets
2015	$30,232
2016	30,232
2017	30,232
2018	30,232
Thereafter	241,837
Intangible assets, Net	$362,764	$392,445

Intangible_Assets_Details_Text

Intangible Assets (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Jan. 15, 2004
	Intangible_Asset	Dec. 31, 2013	Jan. 15, 2004
Intangible Assets (Textual)
Number of intangible assets	2
Impairment of intangible assets	$0	$0
Intangible assets, net	362,764	392,746
Gross amount of acquired intangible assets	663,873	663,374
Patents [Member]
Intangible Assets (Textual)
Aggregate intangible assets, Asset percentage	91.00%
Gross amount of acquired intangible assets	618,150	617,651
Trademarks [Member]
Intangible Assets (Textual)
Aggregate intangible assets, Asset percentage	9.00%
Gross amount of acquired intangible assets	45,723	45,723
Amounts paid to third parties for legal fees, application fees and other direct costs	507,871
Patents and Trademarks [Member]
Intangible Assets (Textual)
Gross amount of acquired intangible assets			$156,002

Notes_Payable_Details

Notes Payable (Details) (USD $)	Dec. 31, 2014
Summary of future principal payments of Frisco note payable
2015	$718,533
Note payable, Total	718,533
Frisco Note payable [Member]
Summary of future principal payments of Frisco note payable
2015	52,000
2016	52,000
Note payable, Total	$104,000

Notes_Payable_Details_1

Notes Payable (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Carrying values of short-term and long-term notes payable
Effective Interest Rate		12.34%
Total short-term notes payable, Principal	$1,327,958	$481,500
Total short term notes accrued interest	23,116	27,997
Total short-term notes payable, Discount	632,542	207,596
Total short-term notes payable	718,533	301,901
Total long-term notes payable, Principal	0	104,000
Total Long term notes accrued interest	0	0
Total long-term notes payable, Discount	0	27,928
Total long-term notes payable	0	76,072
Total short-term and long-term notes payable, Principal	1,327,958	585,500
Total short and long term notes accrued interest	23,116	27,997
Total short-term and long-term notes payable, Discount	632,541	235,524
Total short-term and long-term notes payable	718,533	377,973
Iliad Trading and Research Notes [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	1.50%	47.30%
Total short-term notes payable, Principal	157,458	165,000
Total short term notes accrued interest	2,346	5,004
Total short-term notes payable, Discount		72,980
Total short-term notes payable	159,804	97,024
Union Capital Funding Notes [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	69.90%
Total short-term notes payable, Principal	297,000
Total short term notes accrued interest	4,680
Total short-term notes payable, Discount	202,843
Total short-term notes payable	98,837
LG Capital Funding [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate		53.70%
Total short-term notes payable, Principal		57,500
Total short term notes accrued interest		3,008
Total short-term notes payable, Discount		27,886
Total short-term notes payable		32,622
JMJ Financial [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate		70.40%
Total short-term notes payable, Principal		110,000
Total short term notes accrued interest		13,200
Total short-term notes payable, Discount		64,195
Total short-term notes payable		59,005
Tonaquint, Inc. [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate		47.00%
Total short-term notes payable, Principal		105,000
Total short term notes accrued interest		6,785
Total short-term notes payable, Discount		42,535
Total short-term notes payable		69,250
Frisco EDC [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	12.30%	12.34%
Total short-term notes payable, Principal	104,000	44,000
Total short term notes accrued interest
Total short-term notes payable, Discount	15,516
Total short-term notes payable	88,484	44,000
Frisco EDC, Long-term [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate		12.34%
Total long-term notes payable, Principal		104,000
Total Long term notes accrued interest
Total long-term notes payable, Discount		27,928
Total long-term notes payable	0	76,072
JSJ Investments Notes [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	37.30%
Total short-term notes payable, Principal	300,000
Total short term notes accrued interest	10,685
Total short-term notes payable, Discount	101,124
Total short-term notes payable	209,561
Sojourn Note [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	92.90%
Total short-term notes payable, Principal	30,000
Total short term notes accrued interest	819
Total short-term notes payable, Discount	27,041
Total short-term notes payable	3,778
WHC Capital Note [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	74.50%
Total short-term notes payable, Principal	38,500
Total short term notes accrued interest	405
Total short-term notes payable, Discount	28,293
Total short-term notes payable	10,612
Group 10 Notes [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	64.30%
Total short-term notes payable, Principal	236,000
Total short term notes accrued interest	2,716
Total short-term notes payable, Discount	148,963
Total short-term notes payable	89,753
GEL Notes [Member]
Carrying values of short-term and long-term notes payable
Effective Interest Rate	66.80%
Total short-term notes payable, Principal	165,000
Total short term notes accrued interest	1,465
Total short-term notes payable, Discount	108,761
Total short-term notes payable	$57,704

Notes_Payable_Details_2

Notes Payable (Details 2) (USD $)	Dec. 31, 2014
Aggregate maturities of debt
2015	$718,533
Thereafter
Note payable, Total	$718,533

Notes_Payable_Details_Textual

Notes Payable (Details Textual) (USD $)	0 Months Ended
Notes Payable (Details Textual) (USD $)	Mar. 22, 2011	Dec. 31, 2014	Dec. 31, 2013
Notes Payable (Textual)
Note payable, net		$723,323	$349,975
Frisco Promissory Note [Member]
Notes Payable (Textual)
Amount of renewal and extension forgivable loan	213,000
Debt instrument, payment terms	(i) the full payment of the economic incentives; or (ii) March 31, 2016.
Period of performance for debt	5 years
Renewed debt instrument interest rate	12.34%
Unamortized discount		15,516
Note payable, net		$88,484

Shareholders_Equity_Details_Te

Shareholders' Equity (Details Textual) (USD $)	12 Months Ended
Shareholders' Equity (Details Textual) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Shareholders' Equity (Textual)
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, par value	$0.00	$0.00
Conversion ratio	1.22
Series B preferred stock and warrants issued for cash	$0	($750,000)
Common stock issued in connection with lease extinguishment	66,750
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value	$0.00	$0.00
Common stock issued upon conversion of convertible notes	625,913	462,448
Common stock issued upon conversion of convertible notes, Shares
Common stock issued for cash	29,700	347,364
Common stock issued for cash, Shares
Share issued of Series B preferred stock	130
Common stock issued for cash and warrants	525,000	-216,800
Common stock issued for cash and warrants, Shares
Common stock issued for conversion of rent, Shares
Common stock issued for conversion of rent		423,413
Common stock issued for prepaid rent		162,810
Common stock issued for services, Shares	81,500
Common stock issued for services	64,874	257,837
Common stock issued for exercising options and warrants, Shares
Common stock issued for exercising options and warrants	4,370	4,388
Stock based compensation expense	136,944	61,480
Warrant fair value		0
Beneficial conversion feature	951,423	317,609
Deferred loan costs		48,012
Common stock, Shares issued	28,438,631	25,854,307
Common stock, Shares outstanding	28,438,430	25,854,307
Series A Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	593,750	743,750
Preferred stock, shares outstanding	593,750	743,750
Series A preferred shares converted to common stock	150,000
Preferred stock converted into common stock	183,000
Conversion ratio	1.221
Dividend payable on Series A preferred stock, quarterly, non-cumulative	$0.01
Original issue price of preferred stock	$1
Common stock issued in connection of lease extinguishment, Shares		75,000
Percentage of claim upon liquidation	100.00%
Cash proceeds from conversion		3,000,000
Cash proceeds from conversion, price paid per share		$5
Preferred stock, voting rights		The holder of each share of Series A Preferred has the right to one vote for each share of common stock.
Redemption period maximum		10 years
Redemption period minimum		2 years
Redemption value per share		$1
Common stock issued upon conversion of convertible preferred stock, Shares	150,000
Series B Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	1,145	750
Preferred stock, shares outstanding	1,145	750
Increase in issuance of Series A Preferred stock shares	3,500
Series B preferred issued for cash, Shares	525
Series B preferred stock converted to common stock, Shares	130
Dividend percentage	6.00%
Original issue price of preferred stock	$1,000
Percentage of claim upon liquidation		100.00%
Cash proceeds from conversion, price paid per share	$0.55
Preferred stock, voting rights	The holder of each share of Series B Preferred has the right to one vote for each share of common stock.
Share issued of Series B preferred stock	525
Warrant [Member]
Shareholders' Equity (Textual)
Common stock issued for exercising options and warrants, Shares		438,888
Common stock [Member]
Shareholders' Equity (Textual)
Conversion ratio	1.221
Series B preferred issued for cash
Series B preferred issued for cash, Shares
Series B preferred stock and warrants issued for cash	95
Series B preferred stock converted to common stock, Shares	236,364
Common stock issued in connection with lease extinguishment	30
Common stock issued in connection of lease extinguishment, Shares	75,000
Common stock issued upon conversion of convertible notes	612	193
Common stock issued upon conversion of convertible notes, Shares	1,529,734	482,934
Common stock issued upon conversion of convertible notes, share price		$0.96
Common stock issued for cash	17	268
Common stock issued for cash, Shares	41,580	670,947
Share issue price		$0.52
Common stock issued for cash and warrants		174
Common stock issued for cash and warrants, Shares		435,000
Stock issued for cash and warrants issue price.		$0.50
Common stock issued for conversion of rent, Shares		644,347
Common stock issued for conversion of rent		258
Common stock issued for prepaid rent, Shares		220,013
Common stock issued for prepaid rent		88
Common stock issued for prepaid rent, share price		$0.66
Common stock issued for services, Shares	81,500	322,000
Common stock issued for services	32	129
Share issued for services, issue price		$0.80
Common stock issued for exercising options and warrants, Shares	436,945	438,888
Common stock issued for exercising options and warrants	175	176
Common stock issued upon conversion of convertible preferred stock, Shares	183,000	91,500
Stock issued shares in connection with website development		132,000
Stock issued value in connection with website development		114,180
Stock based compensation expense
Beneficial conversion feature
Deferred loan costs
Preferred Shares Rights [Member]
Shareholders' Equity (Textual)
Preferred stock, shares authorized	25,000,000
Preferred stock, par value	$0.00

Stock_Options_and_Warrants_Det

Stock Options and Warrants (Details) (Stock Options [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary of option activity
Outstanding Options/Warrants, beginning balance	1,568,891	1,459,096
Granted	380,000	135,000
Exercised
Forfeited/Cancelled	-241,403	-25,205
Outstanding Options/Warrants, ending balance	1,707,488	1,568,891
Employee [Member]
Summary of option activity
Outstanding Options/Warrants, beginning balance	1,552,991	1,440,916
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance	0.35	0.38
Granted	380,000	135,000
Granted, Weighted Average Exercise Price	0.52	0.25
Exercised
Exercised, Weighted Average Exercise Price
Forfeited/Cancelled	-225,503	-22,925
Forfeited/Cancelled, Weighted Average Exercise Price	0.91	1.56
Outstanding Options/Warrants, ending balance	1,707,488	1,552,991
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance	0.31	0.35
Non-Employee [Member]
Summary of option activity
Outstanding Options/Warrants, beginning balance	15,900	18,180
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance	2.5	1.15
Granted
Granted, Weighted Average Exercise Price
Exercised
Exercised, Weighted Average Exercise Price
Forfeited/Cancelled	-15,900	-2,280
Forfeited/Cancelled, Weighted Average Exercise Price	2.5	2.5
Outstanding Options/Warrants, ending balance		15,900
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance		2.5

Stock_Options_and_Warrants_Det1

Stock Options and Warrants (Details 1) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary of stock option forfeited/Cancelled under the Plan
Forfeited/Cancelled, Shares	-241,403	-25,205
Employee [Member]
Summary of stock option forfeited/Cancelled under the Plan
Forfeited/Cancelled, Shares	-225,503	-22,925
Forfeited/Cancelled, weighted average exercise price	0.91	1.56
Non-Employee [Member]
Summary of stock option forfeited/Cancelled under the Plan
Forfeited/Cancelled, Shares	-15,900	-2,280
Forfeited/Cancelled, weighted average exercise price	2.5	2.5

Stock_Options_and_Warrants_Det2

Stock Options and Warrants (Details 2)	12 Months Ended
Stock Options and Warrants (Details 2)	Dec. 31, 2014	Dec. 31, 2013
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model
Volatility	83.79%	40.45%
Expected dividend rate	0.00%	0.00%
Minimum [Member]
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model
Expected terms (in years)	5 years	5 years
Risk-free interest rate	0.82%	1.05%
Maximum [Member]
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model
Expected terms (in years)	10 years	10 years
Risk-free interest rate	1.02%	1.74%

Stock_Options_and_Warrants_Det3

Stock Options and Warrants (Details 3) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Beginning of Period [Abstract]
Number Outstanding	1,707,488
Number Exercisable	1,504,988
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Beginning of Period [Abstract]
Range of Exercise Prices, Lower Range Limit	$0.20
Range of Exercise Prices, Upper Range Limit	$0.25
Number Outstanding	1,507,488
Weighted average remaining contractual life, Options Outstanding	4 years 7 months 28 days
Weighted average exercise price, Options Outstanding	$0.25
Number Exercisable	1,417,488
Weighted average remaining contractual life, Options Exercisable	4 years 7 months 28 days
Weighted average exercise price, Options Exercisable	$0.25
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Beginning of Period [Abstract]
Range of Exercise Prices, Lower Range Limit	$0.50
Range of Exercise Prices, Upper Range Limit	$1
Number Outstanding	200,000
Weighted average remaining contractual life, Options Outstanding	4 years 6 months 26 days
Weighted average exercise price, Options Outstanding	$0.89
Number Exercisable	87,500
Weighted average remaining contractual life, Options Exercisable	3 years 10 months 10 days
Weighted average exercise price, Options Exercisable	$0.74

Stock_Options_and_Warrants_Det4

Stock Options and Warrants (Details 4) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Summary of warrants activity
Outstanding Options/Warrants, beginning balance	2,967,009	1,877,034
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance	$1.13	$0.80
Outstanding Warrants, Estimated Life (Years), begining balance	2 years 9 months 22 days	1 year 7 months 24 days
Outstanding Warrants, Intrinsic Value, beginning balance	$0.19	$1.07
Granted	1,467,896	1,576,364
Granted, Weighted Average Exercise Price	$1.26	$1.44
Granted, Estimated Life (Years)	3 years 11 months 12 days	4 years 3 months 18 days
Exercised	-436,945	-438,889
Exercised, Weighted Average Exercise Price	$0.01	$0.01
Forfeited/Cancelled	-468,700	-47,500
Forfeited/Cancelled, Weighted Average Exercise Price	$0.65	$0.69
Exercisable	3,569,260	2,967,009
Exercisable, Weighted Average Exercise Price	$1.37	$1.13
Exercisable, Estimated Life (Years)	3 years 2 months 5 days	2 years 9 months 22 days
Exercisable, Intrinsic Value		$0.19
Outstanding Options/Warrants, ending balance	3,569,260	2,967,009
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance	$1.37	$1.13
Outstanding Warrants, Estimated Life (Years), ending balance	3 years 2 months 5 days	2 years 9 months 22 days
Outstanding Warrants, Intrinsic Value, ending balance		$0.19

Stock_Options_and_Warrants_Det5

Stock Options and Warrants (Details Textual) (USD $)	1 Months Ended	12 Months Ended
Stock Options and Warrants (Details Textual) (USD $)	Apr. 30, 2004	Dec. 31, 2014	Dec. 31, 2013
Stock option and warrants (Textual)
Maximum number of shares acquired under voting stock option plan	5,000,000
Expiration period of option, Maximum	10 years
Expiration period of option, Minimum	5 years
Termination period of option for ineligible individual	90 days
Stock compensation expense recognition requisite service period		5 years
Unrecognized compensation costs related to non-vested stock option		$105,154
Unrecognized compensation costs will be recognized over the weighted average remaining vesting period		1 year 2 months 5 days
Stock based compensation expense		$136,944	$61,480
Employee Stock Option [Member]
Stock option and warrants (Textual)
Stock option/warrant exercised

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of components of net deferred tax assets including valuation allowance
Net operating loss carry-forwards	$5,150,797	$4,129,735
Net deferred tax assets before valuation allowance	5,588,365	4,733,483
Less: Valuation Allowance	-5,588,365	-4,733,483
Net deferred tax assets

Income_Taxes_Details_1

Income Taxes (Details 1)	12 Months Ended
Income Taxes (Details 1)	Dec. 31, 2014	Dec. 31, 2013
Schedule of reconciliation of income tax rate to pre-tax loss
Statutory federal income tax	34.00%	34.00%
Statutory state income tax	-0.22%	-0.92%
Change in valuation allowance on deferred tax assets	-33.51%	-33.69%
Net effective tax rate	-0.27%	-0.61%

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
Income Taxes (Details Textual) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Income Taxes (Textual)
Cumulative net operating loss carry-forwards	$15,150,126	$12,146,279
Cumulative net operating loss carry-forwards expiration date	Between 2024 and 2034.
Deferred income tax	$5,588,365	$4,733,483

Commitments_and_Contingency_De

Commitments and Contingency (Details) (USD $)	Dec. 31, 2014
Summary of future minimum lease payments under non-cancelable operating lease
2015	$194,400
2016	210,600
2017	210,600
Thereafter
Operating leases, Future minimum payments, Total	$615,600

Commitments_and_Contingency_De1

Commitments and Contingency (Details 1) (USD $)	Dec. 31, 2014
Summary of minimum non-cancellable lease payments required under capital leases
2014	$149
Thereafter
Capital leases, future minimum payments, Total	$149

Commitments_and_Contingency_De2

Commitments and Contingency (Details Textual) (USD $)	12 Months Ended
Commitments and Contingency (Details Textual) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2007
Commitments and Contingency (Textual)
Lease Expiration Date		31-Dec-17	31-Oct-12
Rent expense	$194,400	$194,400
Balance outstanding as debt obligation to VenCore Solutions, LLC	307,662
Settlement of debt through common stock	75,000
Balance on Vencore lease	$0

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended
Related Party Transactions (Details) (USD $)	Dec. 31, 2014		Dec. 31, 2013
Summary of related party financings and notes
Stated interest rate			12.34%
Julian Ross [Member]
Summary of related party financings and notes
Amount	$154,850	[1]	$118,627	[1]
Stated interest rate	0.00%	[1]	0.00%	[1]
Maturity	n/a	[1]	n/a	[1]
Other [Member]
Summary of related party financings and notes
Amount
Stated interest rate	0.00%		0.00%
Maturity	n/a		n/a

[1]	Our CEO, Mr. Ross provided us cash and other consideration from time to time to fund to fund working capital. The net amounts outstanding to Mr. Ross were $154,850 and $118,627 as at December 31, 2014 and December 31, 2013, respectively.

Related_Party_Transactions_Det1

Related Party Transactions (Details Textual) (Julian Ross [Member], USD $)	Dec. 31, 2014		Dec. 31, 2013
Julian Ross [Member]
Related Party Transactions (Textual)
Amount outstanding	$154,850	[1]	$118,627	[1]

[1]	Our CEO, Mr. Ross provided us cash and other consideration from time to time to fund to fund working capital. The net amounts outstanding to Mr. Ross were $154,850 and $118,627 as at December 31, 2014 and December 31, 2013, respectively.

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (USD $)	12 Months Ended
Fair Value Measurements (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of changes related to derivatives
Beginning Balance
Additions related to embedded derivative of convertible notes issued	28,009
Gain on decrease in value of derivative liabilities	3,001
Ending Balance	$31,010

Segment_Information_Details

Segment Information (Details) (USD $)	12 Months Ended
Segment Information (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Components of revenue by geographic region
Total revenues	$2,437,402	$1,800,327
United States revenues [Member]
Components of revenue by geographic region
Total revenues	2,380,000	1,302,042
ROW revenues [Member]
Components of revenue by geographic region
Total revenues	$57,402	$498,286

Segment_Information_Details_Te

Segment Information (Details Textual)	12 Months Ended
	Dec. 31, 2013
	Segments
Segment Information (Textual)
Number of reportable segments	1

Going_Concern_Details

Going Concern (Details) (USD $)	12 Months Ended
Going Concern (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Going Concern (Textual)
Notes Payable	$723,323	$349,975
Increase in notes payable, current	678,839	273,903
Notes payable, noncurrent	44,484	76,072
Accumulated deficit	-18,041,208	-15,287,647
Working capital	418,734	747,473
NET CASH USED IN OPERATING ACTIVITIES	($1,099,349)	($860,791)

Concentration_of_Risk_in_Custo2

Concentration of Risk in Customer and Supplier Relationships (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Knight Aerospace, Inc. [Member]
Concentration Risk [Line Items]
Percentage of revenues	58.00%	35.00%
PP Aviation Corporation [Member]
Concentration Risk [Line Items]
Percentage of revenues	19.00%	28.00%

Concentration_of_Risk_in_Custo3

Concentration of Risk in Customer and Supplier Relationships (Details Textual)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
	Customers	Customers
Concentration of Risk in Customer and Supplier Relationships (Textual)
Number of customers accounted for significant revenues	2	2

Subsequent_Events_Details

Subsequent Events (Details) (Subsequent Event [Member], USD $)	0 Months Ended
	Jan. 12, 2015
Subsequent Events (Textual)
Common stock issued for conversion of Series B preferred	318,349
Series B Preferred stock converted into common stock	170
Common stock issued for conversions of convertible notes	602,426
Stock issued for connection in licensing and marketing agreement	30,000
Stock issued for connection in investment banking agreement	58,000
Julian T.Ross [Member]
Subsequent Events (Textual)
Term of agreement	3 years
Basic salary	275,000
Annual Bonus description	40% of Base Salary, provided that: (i) 30% of the Annual Bonus is subject to achievement of MBOs (Management by Objectives) determined by the Board; (ii) 70% of the Annual Bonus is subject to achievement of financial performance metrics set by the Board (for example, Revenue or Revenue Growth, Stock Price, and so forth).
Stock options value	200,000
Restricted stock units description	(i) Base Restricted Stock Units ("RSUs"): $100,000 per year; Up to an additional $200,000 per year at the Board's sole and absolute discretion. (ii) Performance Restricted Stock Units: 150,000 units subject to achieving both positive net earnings and positive EBITDA for a 6 month period (one time issuance).